Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0KW4 stock hub

LON/0KW4 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0KW4is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

22B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0KW4

In the news

Latest news · LON/0KW4

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.3

P25 12.9P50 16.9P75 23.5

Trailing P/E19.1

P25 15.9P50 22.9P75 35.8

ROE25.2

P25 -54.2P50 2.1P75 13.7

ROIC26.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0KW4 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	10,600
Employees Change	620%
Employees Change Percent	6.21
Enterprise value	$21.4B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US7611521078
Last refreshed	2026-05-10
Market cap	$22B
Price	$207
Price currency	USD
Rev Per Employee	395,641.07x
Sector	Healthcare
Sic	3845
Symbol	lon/0KW4
Website	https://www.resmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.23%
EV Earnings	18.61x
EV/EBIT	15.11x
EV/EBITDA	13.49x
EV/FCF	16.12x
EV/Sales	5.27x
FCF yield	6.04%
Forward P/E	17.33x
P/B ratio	4.48x
P/E ratio	19.13x
P/S ratio	5.25x
PE Ratio10 Y	38.74x
PE Ratio3 Y	27.5x
PE Ratio5 Y	37.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.76%
EBITDA Margin	38.27%
FCF margin	31.68%
Gross margin	62.18%
Gross Profit	$2.6B
Gross Profit Growth	15.51%
Gross Profit Growth Q	16.15%
Gross Profit Growth3 Y	14.58%
Gross Profit Growth5 Y	13.24%
Net Income	$1.2B
Net Income Growth	15.71%
Net Income Growth Q	9.23%
Net Income Growth Quarters	9%
Net Income Growth Years	4%
Net Income Growth3 Y	20.76%
Net Income Growth5 Y	27.15%
Pretax Margin	34.37%
Profit Margin	27.44%
Profit Per Employee	$108,564
Profitable Years	33
ROA	14.72
Roa5y	12.79
ROCE	25.9
ROE	25.25
Roe5y	23.02
ROIC	26.9
Roic5y	20.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-14.29%
Cagr3y	-3.04%
Cagr5y	2.05%
Div CAGR3	6.05%
Div CAGR5	7.83%
EPS Growth	16.39
EPS Growth Q	10.48
EPS Growth Quarters	9
EPS Growth Years	4
EPS Growth3 Y	20.96
EPS Growth5 Y	27.08
FCF Growth	11.82%
FCF Growth Q	-6.7%
FCF Growth3 Y	60.86%
FCF Growth5 Y	18.6%
OCF Growth	14.34%
OCF Growth Q	-4.24%
OCF Growth10 Y	14.12%
OCF Growth3 Y	52.27%
OCF Growth5 Y	17.59%
Revenue Growth	10.28x
Revenue Growth Q	10.81x
Revenue Growth Quarters	20x
Revenue Growth Years	32x
Revenue Growth3 Y	11.31x
Revenue Growth5 Y	12.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.68
Assets	$6.7B
Cash	$1.3B
Current Assets	$3B
Current Liabilities	$991.1M
Debt	$638.5M
Debt EBITDA	$0.39
Debt Equity	$0.13
Debt FCF	$0.48
Equity	$4.9B
Liabilities	$1.7B
Long Term Assets	$3.7B
Long Term Liabilities	$744.9M
Net Cash	$619M
Net Cash By Market Cap	$2.81
Net Cash Growth	779.44%
Net Debt EBITDA	$-0.39
Net Debt Equity	$-0.13
Net Debt FCF	$-0.47
Tangible Book Value	$2.3B
Tangible Book Value Per Share	$15.79
WACC	8.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.01
Inventory Turnover	2.24
Net Working Capital	$1B
Quick ratio	2
Working Capital	$2.1B
Working Capital Turnover	$1.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.62%
Dividend Growth	6.73%
Dividend Growth Years	4%
Dividend per share	$1.74
Dividend Years	9
Dividend Yield	0.84%
Ex Div Date	2026-02-12
Last Dividend	$0.44
Payout Frequency	Quarterly
Payout Ratio	22.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-14.28%
200-day SMA	254.7
3Y total return	-8.84%
50-day SMA	228.8
50-day SMA vs 200-day SMA	50under200
5Y total return	10.67%
All Time High	298.4
All Time High Change	-30.75%
All Time High Date	2021-09-09
All Time Low	89.26
All Time Low Change	131.49%
All Time Low Date	2018-02-09
ATR	6.97
Beta	0.85
Ch YTD	-14.85
High	211.4
High52	298
High52 Date	2025-08-25
High52ch	-30.66%
Low	204
Low52	198.7
Low52 Date	2026-05-01
Low52ch	4.02%
Ma50ch	-9.67%
Price vs 200-day SMA	-18.86%
RSI	30.35
RSI Monthly	41.84
RSI Weekly	31.46
Sharpe ratio	-0.75x
Sortino ratio	-0.76
Total Return	1.46%
Tr YTD	-14.65
Tr1m	-8.99%
Tr1w	0.45%
Tr3m	-23.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$1.5B
Operating Income Growth	19.41
Operating Income Growth Q	18.63
Operating Income Growth3 Y	19.68
Operating Income Growth5 Y	16.44
Operating margin	34.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144,169,809%
Net Borrowing	-7,335,140
Shares Insiders	0.52%
Shares Institutions	76.08%
Shares Qo Q	-0.44%
Shares Yo Y	-0.62%
Short Ratio	10.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.3B
Average Volume	690.35x
Bv Per Share	33.9
CAPEX	$-102.8M
Ch1m	-8.99
Ch1w	0.45
Ch1y	-15.04
Ch3m	-23.87
Ch3y	-11.38
Ch5y	5.99
Ch6m	-17.25
Change	-0.31%
Change From Open	0.04
Close	207.3
Days Gap	-0.35
Depreciation Amortization	142,759,428.7
Dollar Volume	83,271.9
Earnings Date	2026-04-30
EBIT	$1.5B
EBITDA	$1.6B
EPS	$7.85
F Score	6
FCF	$1.3B
FCF EV Yield	6.2x
Financing CF	-687,445,128
Fiscal Year End	June
Founded	1,989
Goodwill	2,232,182,859.9
Graham Number	105.91881
Graham Upside	-48.74
Income Tax	$290.6M
Investing CF	-223,602,632
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$270
Lynch Upside	30.71
Ma150	247
Ma150ch	-16.34%
Ma20	218
Ma20ch	-5.23%
Net CF	551,168,094
Next Earnings Date	2026-07-30
Open	206.6
P FCF Ratio	16.57
P OCF Ratio	15.38
Payment Date	2026-03-19
Position In Range	35.54
Ppne	534,419,229
Price Date	2026-05-08
Price EBITDA	$13.71
Ptbv Ratio	9.61
Relative Volume	0.65x
Revenue	4,193,795,299x
SBC By Revenue	1.84x
Share Based Comp	76,973,238
Tax By Revenue	6.93x
Tax Rate	20.16%
Tr6m	-16.86%
Volume	403
Z Score	12.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0KW4 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$1.74 annual per share

Payout ratio

+22.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.8%

4 consecutive years of growth

Total shareholder yield

+1.5%

Next ex-dividend date: 2026-02-12

Performance

LON/0KW4 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0KW4?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.1%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0KW4 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.4

Neutral momentum band

Price vs 200-day MA

-18.9%

50/200-day relationship not available

Beta (5Y)

0.84

Moves roughly with the market

Sharpe ratio

-0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0KW4

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0KW4 stock rating?

lon/0KW4 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0KW4 analysis?

The full report lives at /stocks/lon/0KW4/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0KW4?

The latest report frames lon/0KW4 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0KW4 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.